...
首页> 外文期刊>Oncogene >The aurora kinase A regulates GSK-3|[beta]| in gastric cancer cells
【24h】

The aurora kinase A regulates GSK-3|[beta]| in gastric cancer cells

机译:极光激酶A调节GSK-3 |β|在胃癌细胞中

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Aurora kinase A (AURKA) is located at 20q13, a region that is frequently amplified in gastric cancer. In this study, we have investigated the role of AURKA in regulating glycogen synthase kinase (GSK)-3β and β-catenin/TCF complex in gastric cancer cells. Our results demonstrate a significant increase in the phosphorylation of GSK-3β at Ser 9 following the overexpression of AURKA in AGS cells. The immunoprecipitation with antibodies specific for AURKA and GSK-3β indicated that the two proteins coexist in the same protein complex. The recombinant human AURKA protein phosphorylated the GSK-3β protein at Ser 9 in a concentration-dependent manner, in vitro. The phosphorylation of β-catenin (Ser33/37/Thr41) by GSK-3β is known to target β-catenin towards degradation. In line with our findings, the increase in phospho-GSK-3β level was accompanied by a significant decrease in β-catenin phosphorylation (Ser33/37/Thr41) and accumulation of β-catenin protein. The knockdown of AURKA reversed the phosphorylation of GSK-3β and the β-catenin protein levels. The immunofluorescence analysis demonstrated colocalization of AURKA and GSK-3β proteins and a significant increase in the nuclear β-catenin levels in cells overexpressing AURKA. The β-catenin/TCF transcription activity was measured using the pTopFlash and its mutant pFopFlash luciferase reporter vectors. Indeed, AURKA overexpression led to a significant increase in the pTopFlash reporter activity, whereas kinase dead AURKA mutant (D274A) had no effect. Consistent with these findings, we detected a significant mRNA up-regulation of several direct targets of the β-catenin/TCF transcription complex (cyclin D1, c-MYC, c-MYC-binding protein, CLDN1, FGF18 and vascular endothelial growth factor), and a two-fold increase in the proliferation rate in AURKA overexpressing cells. We conclude that the AURKA/GSK-3β interaction is important in regulating β-catenin, underscoring a novel oncogenic potential for AURKA in gastric tumorigenesis.
机译:极光激酶A(AURKA)位于20q13,在胃癌中经常扩增。在这项研究中,我们研究了AURKA在调节胃癌细胞中糖原合酶激酶(GSK)-3β和β-catenin/ TCF复合物中的作用。我们的结果表明,在AGS细胞中过表达AURKA后,Ser 9处GSK-3β的磷酸化显着增加。用对AURKA和GSK-3β特异的抗体进行的免疫沉淀表明,这两种蛋白共存于同一蛋白复合物中。重组人AURKA蛋白在体外以浓度依赖性方式磷酸化Ser 9处的GSK-3β蛋白。已知GSK-3β对β-catenin(Ser33 / 37 / Thr41)的磷酸化将β-catenin靶向降解。与我们的发现一致,磷酸-GSK-3β水平的增加伴随着β-catenin磷酸化(Ser33 / 37 / Thr41)和β-catenin蛋白积累的显着下降。敲低AURKA逆转了GSK-3β的磷酸化和β-catenin蛋白水平。免疫荧光分析表明AURKA和GSK-3β蛋白共定位,并且过表达AURKA的细胞中核β-连环蛋白水平显着增加。使用pTopFlash及其突变的pFopFlash荧光素酶报告载体测量β-catenin/ TCF转录活性。实际上,AURKA过表达导致pTopFlash报告基因活性显着增加,而激酶死亡的AURKA突变体(D274A)没有作用。与这些发现一致,我们检测到了β-catenin/ TCF转录复合体的几个直接靶标(cyclin D1,c-MYC,c-MYC结合蛋白,CLDN1,FGF18和血管内皮生长因子)的显着mRNA上调,并且AURKA过表达细胞的增殖速率提高了两倍。我们得出结论,AURKA /GSK-3β相互作用在调节β-catenin方面很重要,强调了AURKA在胃肿瘤发生中的新型致癌潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号